Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and to examine the index of the efficacy after repeated dosing of CNT-01 in patients with idiopathic triglyceride deposit cardiomyovasculopathy.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Idiopathic Triglyceride Deposit Cardiomyovasculopathy

NCT number NCT02502578
Study type Interventional
Source Osaka University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date September 2015